

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.47736008 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.47736008 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.10957772 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.10957772 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.93987463 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.52033002 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.52033002 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.52033002 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.33041016 |
| 10 | bile acid biosynthetic process (GO:0006699) | 6.25897095 |
| 11 | tryptophan metabolic process (GO:0006568) | 6.08744493 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.87672569 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.81973601 |
| 14 | urea metabolic process (GO:0019627) | 5.81750621 |
| 15 | urea cycle (GO:0000050) | 5.81750621 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78067632 |
| 17 | regulation of protein activation cascade (GO:2000257) | 5.71501226 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54602684 |
| 19 | regulation of complement activation (GO:0030449) | 5.42941114 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.35852816 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 5.34068761 |
| 22 | protein carboxylation (GO:0018214) | 5.32713387 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.32713387 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.26006034 |
| 25 | cysteine metabolic process (GO:0006534) | 5.24362507 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.18868271 |
| 27 | water-soluble vitamin biosynthetic process (GO:0042364) | 5.18646049 |
| 28 | bile acid metabolic process (GO:0008206) | 5.13597410 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.13450104 |
| 30 | DNA deamination (GO:0045006) | 5.10778694 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 5.08569612 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.99917659 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.91958067 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.84746154 |
| 35 | coenzyme catabolic process (GO:0009109) | 4.79923474 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.70152888 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.66789408 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 4.59538898 |
| 39 | sulfation (GO:0051923) | 4.59316483 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.58440221 |
| 41 | lysine catabolic process (GO:0006554) | 4.58130567 |
| 42 | lysine metabolic process (GO:0006553) | 4.58130567 |
| 43 | cellular biogenic amine catabolic process (GO:0042402) | 4.51757288 |
| 44 | amine catabolic process (GO:0009310) | 4.51757288 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.50162699 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.45872200 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.45872200 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45872200 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.45802193 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.44751372 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.44751372 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 4.37170020 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.34732942 |
| 54 | imidazole-containing compound metabolic process (GO:0052803) | 4.33403555 |
| 55 | cytolysis (GO:0019835) | 4.31453868 |
| 56 | glutamate metabolic process (GO:0006536) | 4.26983721 |
| 57 | phospholipid efflux (GO:0033700) | 4.25301694 |
| 58 | glycine metabolic process (GO:0006544) | 4.23548924 |
| 59 | cellular glucuronidation (GO:0052695) | 4.22195527 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.20519894 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.17332178 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.17332178 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.16588521 |
| 64 | ethanol oxidation (GO:0006069) | 4.15066358 |
| 65 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.14542381 |
| 66 | behavioral response to nicotine (GO:0035095) | 4.12865609 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.12712674 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.12158691 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 4.09196289 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 4.08261077 |
| 71 | fibrinolysis (GO:0042730) | 4.03101937 |
| 72 | complement activation, classical pathway (GO:0006958) | 4.01886138 |
| 73 | cholesterol efflux (GO:0033344) | 4.01227890 |
| 74 | cofactor catabolic process (GO:0051187) | 3.99886395 |
| 75 | arginine metabolic process (GO:0006525) | 3.96718906 |
| 76 | aldehyde catabolic process (GO:0046185) | 3.96418838 |
| 77 | complement activation (GO:0006956) | 3.92770667 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.89850421 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.80871200 |
| 80 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80622699 |
| 81 | protein activation cascade (GO:0072376) | 3.80444560 |
| 82 | uronic acid metabolic process (GO:0006063) | 3.78059047 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.78059047 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77008588 |
| 85 | phospholipid homeostasis (GO:0055091) | 3.76901391 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.73961598 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 3.71172721 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.69771893 |
| 89 | NAD biosynthetic process (GO:0009435) | 3.65841244 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.64035701 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.63460674 |
| 92 | organic acid catabolic process (GO:0016054) | 3.63460674 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.63007070 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60896334 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60896334 |
| 96 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59946241 |
| 97 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59946241 |
| 98 | sterol homeostasis (GO:0055092) | 3.58214046 |
| 99 | drug catabolic process (GO:0042737) | 3.57081429 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55900596 |
| 101 | ketone body metabolic process (GO:1902224) | 3.52655028 |
| 102 | exogenous drug catabolic process (GO:0042738) | 3.48167937 |
| 103 | urate metabolic process (GO:0046415) | 3.44994004 |
| 104 | plasma lipoprotein particle organization (GO:0071827) | 3.42231174 |
| 105 | opsonization (GO:0008228) | 3.41381316 |
| 106 | cellular response to ATP (GO:0071318) | 3.35853770 |
| 107 | cytidine metabolic process (GO:0046087) | 3.33704875 |
| 108 | cytidine catabolic process (GO:0006216) | 3.33704875 |
| 109 | cytidine deamination (GO:0009972) | 3.33704875 |
| 110 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.21335026 |
| 111 | cell proliferation in forebrain (GO:0021846) | 3.12384634 |
| 112 | negative regulation of telomere maintenance (GO:0032205) | 3.08241386 |
| 113 | platelet dense granule organization (GO:0060155) | 3.07407564 |
| 114 | regulation of glomerulus development (GO:0090192) | 3.05035100 |
| 115 | flavonoid metabolic process (GO:0009812) | 3.02991256 |
| 116 | oxidative demethylation (GO:0070989) | 3.02179334 |
| 117 | L-fucose catabolic process (GO:0042355) | 2.99288103 |
| 118 | fucose catabolic process (GO:0019317) | 2.99288103 |
| 119 | L-fucose metabolic process (GO:0042354) | 2.99288103 |
| 120 | negative regulation of mast cell activation (GO:0033004) | 2.96247906 |
| 121 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.95169964 |
| 122 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.95169964 |
| 123 | S-adenosylmethionine metabolic process (GO:0046500) | 2.93127034 |
| 124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.89034891 |
| 125 | regulation of DNA endoreduplication (GO:0032875) | 2.86758757 |
| 126 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.85533475 |
| 127 | isotype switching (GO:0045190) | 2.85533475 |
| 128 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.85533475 |
| 129 | positive regulation of mRNA catabolic process (GO:0061014) | 2.84717456 |
| 130 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.84381951 |
| 131 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.82798675 |
| 132 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.81370586 |
| 133 | positive regulation of fatty acid oxidation (GO:0046321) | 2.77312814 |
| 134 | positive regulation of defense response to virus by host (GO:0002230) | 2.76471166 |
| 135 | positive regulation of protein autophosphorylation (GO:0031954) | 2.74984077 |
| 136 | tolerance induction (GO:0002507) | 2.74053991 |
| 137 | protein polyglutamylation (GO:0018095) | 2.73102241 |
| 138 | indole-containing compound metabolic process (GO:0042430) | 2.73096588 |
| 139 | vitamin biosynthetic process (GO:0009110) | 2.69500839 |
| 140 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.68352781 |
| 141 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.66662879 |
| 142 | negative regulation of protein autophosphorylation (GO:0031953) | 2.65217462 |
| 143 | regulation of germinal center formation (GO:0002634) | 2.64960695 |
| 144 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.64640232 |
| 145 | positive regulation of fatty acid transport (GO:2000193) | 2.64422093 |
| 146 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.59761944 |
| 147 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.59761944 |
| 148 | kidney morphogenesis (GO:0060993) | 2.59664749 |
| 149 | adaptation of signaling pathway (GO:0023058) | 2.59627999 |
| 150 | cellular response to interleukin-15 (GO:0071350) | 2.56568576 |
| 151 | regulation of glucokinase activity (GO:0033131) | 2.54302302 |
| 152 | regulation of hexokinase activity (GO:1903299) | 2.54302302 |
| 153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.51566376 |
| 154 | limb bud formation (GO:0060174) | 2.48786675 |
| 155 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.48548546 |
| 156 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.47650327 |
| 157 | NADH dehydrogenase complex assembly (GO:0010257) | 2.47650327 |
| 158 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.47650327 |
| 159 | negative T cell selection (GO:0043383) | 2.45181107 |
| 160 | DNA double-strand break processing (GO:0000729) | 2.43722843 |
| 161 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.39242318 |
| 162 | gamma-aminobutyric acid transport (GO:0015812) | 2.38539540 |
| 163 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.38465836 |
| 164 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.38101307 |
| 165 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.37741168 |
| 166 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.37405595 |
| 167 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.36568492 |
| 168 | detection of light stimulus involved in visual perception (GO:0050908) | 2.36568492 |
| 169 | protein complex biogenesis (GO:0070271) | 2.36536482 |
| 170 | prostate gland growth (GO:0060736) | 2.36117151 |
| 171 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.36072529 |
| 172 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.36072529 |
| 173 | negative regulation by host of viral transcription (GO:0043922) | 2.35681280 |
| 174 | regulation of sequestering of triglyceride (GO:0010889) | 2.34912806 |
| 175 | GPI anchor metabolic process (GO:0006505) | 2.33892413 |
| 176 | positive regulation of icosanoid secretion (GO:0032305) | 2.33697556 |
| 177 | regulation of gene silencing by miRNA (GO:0060964) | 2.33268536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.09825700 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.94579527 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.90499679 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33522946 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.17573841 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.69623034 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.41590422 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00551911 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.65796522 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.23537276 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.70695440 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.61347549 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.48830394 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46633580 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.38949918 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.32735152 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.28646085 |
| 18 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27688812 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.21637884 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 2.11948784 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.11029124 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.05321145 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.01959478 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01012396 |
| 25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00620579 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5590088 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.99764033 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96584286 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93187219 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.91971826 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89595655 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.88325289 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.86489412 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.84419697 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84147344 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.77848439 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.76328420 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.76016610 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.74807841 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73270496 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.71377208 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.68093458 |
| 43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.66142352 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65539227 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.64671510 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60194750 |
| 47 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60147595 |
| 48 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.54923697 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53101085 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51854264 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50968256 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49824846 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49761471 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.49492027 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48210615 |
| 56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47795248 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47663027 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47490746 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47490746 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44483786 |
| 61 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.43806331 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43139179 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.42934738 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42492040 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41919713 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40121779 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40096216 |
| 68 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36239824 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34965629 |
| 70 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31348293 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31348293 |
| 72 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30459723 |
| 73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30112146 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29875901 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27166427 |
| 76 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26400280 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25902171 |
| 78 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.22795514 |
| 79 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.22795514 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22544168 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22511884 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22335292 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22126381 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21931047 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21610094 |
| 86 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19790759 |
| 87 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17561200 |
| 88 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16054961 |
| 89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16020142 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14885471 |
| 91 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14619294 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14572882 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14385277 |
| 94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13535267 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12970158 |
| 96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11571481 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11497803 |
| 98 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11442186 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10910538 |
| 100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10230411 |
| 101 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10032673 |
| 102 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08500779 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08460973 |
| 104 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08184503 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08088780 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07612800 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06934173 |
| 108 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05312484 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04576790 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02625881 |
| 111 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02419423 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02285245 |
| 113 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97353819 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91446122 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90746238 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85002177 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84195898 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82470373 |
| 119 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82386381 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80347061 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80347061 |
| 122 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78959421 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78816896 |
| 124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76523173 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75580415 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74279871 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72328690 |
| 128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72250677 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71489614 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70832124 |
| 131 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70502478 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70279241 |
| 133 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69317051 |
| 134 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69005755 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66871259 |
| 136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66690586 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.66176141 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66139562 |
| 139 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.62606830 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60897174 |
| 141 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.58758672 |
| 142 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58203227 |
| 143 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57999782 |
| 144 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56320702 |
| 145 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55868163 |
| 146 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54747628 |
| 147 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53874967 |
| 148 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.52596130 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52485914 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51867795 |
| 151 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.51800038 |
| 152 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51563738 |
| 153 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.49442715 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48965135 |
| 155 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48769003 |
| 156 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47291270 |
| 157 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.47044769 |
| 158 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.46752386 |
| 159 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46659087 |
| 160 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45657216 |
| 161 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44782073 |
| 162 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44720739 |
| 163 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.44705870 |
| 164 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44359295 |
| 165 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44283141 |
| 166 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.44257067 |
| 167 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.44106815 |
| 168 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44010458 |
| 169 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43627771 |
| 170 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43620719 |
| 171 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42959469 |
| 172 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42618431 |
| 173 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42493718 |
| 174 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42309763 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42115692 |
| 176 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40955714 |
| 177 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40881306 |
| 178 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40333941 |
| 179 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39747049 |
| 180 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39441776 |
| 181 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39329148 |
| 182 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39107716 |
| 183 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38549058 |
| 184 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.37950821 |
| 185 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37455310 |
| 186 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37085126 |
| 187 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36886377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.10557008 |
| 2 | MP0005360_urolithiasis | 7.58381639 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43377552 |
| 4 | MP0005365_abnormal_bile_salt | 6.06531196 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.80789768 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08614286 |
| 7 | MP0003252_abnormal_bile_duct | 4.03751116 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.47178309 |
| 9 | MP0005083_abnormal_biliary_tract | 3.20484391 |
| 10 | MP0009840_abnormal_foam_cell | 3.06982243 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.84490401 |
| 12 | MP0003195_calcinosis | 2.80169599 |
| 13 | MP0005332_abnormal_amino_acid | 2.71796267 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.59062853 |
| 15 | MP0002102_abnormal_ear_morphology | 2.57598248 |
| 16 | MP0005671_abnormal_response_to | 2.54055476 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.34956889 |
| 18 | MP0000609_abnormal_liver_physiology | 2.15816118 |
| 19 | MP0002163_abnormal_gland_morphology | 2.13885677 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.08909418 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.08377597 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.08025533 |
| 23 | MP0004134_abnormal_chest_morphology | 2.03007912 |
| 24 | MP0002160_abnormal_reproductive_system | 1.92412540 |
| 25 | MP0003868_abnormal_feces_composition | 1.91552755 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.82914773 |
| 27 | MP0005389_reproductive_system_phenotype | 1.79065632 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.75016944 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.73427511 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.69035941 |
| 31 | MP0005379_endocrine/exocrine_gland_phen | 1.67680268 |
| 32 | MP0001764_abnormal_homeostasis | 1.62980385 |
| 33 | MP0003787_abnormal_imprinting | 1.62327122 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.60612837 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.59174424 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.57795078 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.57369470 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55157777 |
| 39 | MP0003646_muscle_fatigue | 1.54282038 |
| 40 | MP0004142_abnormal_muscle_tone | 1.44375927 |
| 41 | MP0009697_abnormal_copulation | 1.40012925 |
| 42 | MP0001873_stomach_inflammation | 1.38856162 |
| 43 | MP0003011_delayed_dark_adaptation | 1.38326145 |
| 44 | MP0001800_abnormal_humoral_immune | 1.36166939 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.32811689 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.31051098 |
| 47 | MP0000685_abnormal_immune_system | 1.30257347 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.30255067 |
| 49 | MP0005451_abnormal_body_composition | 1.29349907 |
| 50 | MP0001835_abnormal_antigen_presentation | 1.29180761 |
| 51 | MP0004885_abnormal_endolymph | 1.28641553 |
| 52 | MP0005647_abnormal_sex_gland | 1.27418241 |
| 53 | MP0001919_abnormal_reproductive_system | 1.23355556 |
| 54 | MP0009764_decreased_sensitivity_to | 1.22176803 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.20888662 |
| 56 | MP0003186_abnormal_redox_activity | 1.20048403 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.19590404 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.18668839 |
| 59 | MP0000598_abnormal_liver_morphology | 1.16617294 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.16437093 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.16325007 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.16249039 |
| 63 | MP0000604_amyloidosis | 1.15578078 |
| 64 | MP0002254_reproductive_system_inflammat | 1.12952673 |
| 65 | MP0005253_abnormal_eye_physiology | 1.09193584 |
| 66 | MP0009763_increased_sensitivity_to | 1.08231783 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.06897404 |
| 68 | MP0003786_premature_aging | 1.04488108 |
| 69 | MP0002723_abnormal_immune_serum | 1.02761454 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.01521312 |
| 71 | MP0008469_abnormal_protein_level | 1.01389593 |
| 72 | MP0004133_heterotaxia | 1.00934768 |
| 73 | MP0005000_abnormal_immune_tolerance | 1.00927796 |
| 74 | MP0002282_abnormal_trachea_morphology | 0.98772062 |
| 75 | MP0000689_abnormal_spleen_morphology | 0.97034231 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 0.96191395 |
| 77 | MP0000049_abnormal_middle_ear | 0.95426678 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.94605239 |
| 79 | MP0008058_abnormal_DNA_repair | 0.94463467 |
| 80 | MP0000613_abnormal_salivary_gland | 0.94352388 |
| 81 | MP0005387_immune_system_phenotype | 0.93343112 |
| 82 | MP0001790_abnormal_immune_system | 0.93343112 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.92964014 |
| 84 | MP0002272_abnormal_nervous_system | 0.92044450 |
| 85 | MP0000569_abnormal_digit_pigmentation | 0.91568817 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.90522021 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.90083684 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.88909591 |
| 89 | MP0002420_abnormal_adaptive_immunity | 0.88285286 |
| 90 | MP0009745_abnormal_behavioral_response | 0.87767902 |
| 91 | MP0001819_abnormal_immune_cell | 0.86858077 |
| 92 | MP0002736_abnormal_nociception_after | 0.86185206 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.86127324 |
| 94 | MP0002452_abnormal_antigen_presenting | 0.85756189 |
| 95 | MP0002006_tumorigenesis | 0.85141623 |
| 96 | MP0003866_abnormal_defecation | 0.84353388 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.83421765 |
| 98 | MP0001119_abnormal_female_reproductive | 0.82936399 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.81970686 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.80841674 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.80732152 |
| 102 | MP0003283_abnormal_digestive_organ | 0.80401460 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.78267512 |
| 104 | MP0003690_abnormal_glial_cell | 0.77652678 |
| 105 | MP0005408_hypopigmentation | 0.77593606 |
| 106 | MP0005535_abnormal_body_temperature | 0.77574022 |
| 107 | MP0001984_abnormal_olfaction | 0.77135867 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.76867614 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.76473487 |
| 110 | MP0005310_abnormal_salivary_gland | 0.74915680 |
| 111 | MP0003436_decreased_susceptibility_to | 0.74479110 |
| 112 | MP0008995_early_reproductive_senescence | 0.74337128 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.74206193 |
| 114 | MP0004130_abnormal_muscle_cell | 0.73265749 |
| 115 | MP0003329_amyloid_beta_deposits | 0.72984151 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.72090315 |
| 117 | MP0005670_abnormal_white_adipose | 0.72023140 |
| 118 | MP0002971_abnormal_brown_adipose | 0.71930358 |
| 119 | MP0003724_increased_susceptibility_to | 0.71684018 |
| 120 | MP0002938_white_spotting | 0.70990792 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.70413862 |
| 122 | MP0005334_abnormal_fat_pad | 0.69959390 |
| 123 | MP0004381_abnormal_hair_follicle | 0.68475688 |
| 124 | MP0001177_atelectasis | 0.67447722 |
| 125 | MP0004742_abnormal_vestibular_system | 0.67438059 |
| 126 | MP0000716_abnormal_immune_system | 0.66573936 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.66104214 |
| 128 | MP0002928_abnormal_bile_duct | 0.62149965 |
| 129 | MP0005266_abnormal_metabolism | 0.62109786 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.61526723 |
| 131 | MP0006082_CNS_inflammation | 0.61424670 |
| 132 | MP0005166_decreased_susceptibility_to | 0.57368334 |
| 133 | MP0001661_extended_life_span | 0.56551429 |
| 134 | MP0000579_abnormal_nail_morphology | 0.54710521 |
| 135 | MP0003075_altered_response_to | 0.54216792 |
| 136 | MP0005448_abnormal_energy_balance | 0.53953661 |
| 137 | MP0001756_abnormal_urination | 0.53467262 |
| 138 | MP0000639_abnormal_adrenal_gland | 0.53314774 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.51789441 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.50353179 |
| 141 | MP0008874_decreased_physiological_sensi | 0.47972790 |
| 142 | MP0005395_other_phenotype | 0.47042556 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.46254896 |
| 144 | MP0009053_abnormal_anal_canal | 0.45275548 |
| 145 | MP0005058_abnormal_lysosome_morphology | 0.44949322 |
| 146 | MP0001853_heart_inflammation | 0.44625461 |
| 147 | MP0008873_increased_physiological_sensi | 0.44068211 |
| 148 | MP0003638_abnormal_response/metabolism_ | 0.43642117 |
| 149 | MP0002822_catalepsy | 0.43281345 |
| 150 | MP0009785_altered_susceptibility_to | 0.41101928 |
| 151 | MP0009379_abnormal_foot_pigmentation | 0.40973476 |
| 152 | MP0001845_abnormal_inflammatory_respons | 0.40722904 |
| 153 | MP0002796_impaired_skin_barrier | 0.40208997 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.39544446 |
| 155 | MP0003953_abnormal_hormone_level | 0.37158410 |
| 156 | MP0002168_other_aberrant_phenotype | 0.37054114 |
| 157 | MP0003718_maternal_effect | 0.37033707 |
| 158 | MP0001881_abnormal_mammary_gland | 0.36418040 |
| 159 | MP0004947_skin_inflammation | 0.35635448 |
| 160 | MP0010234_abnormal_vibrissa_follicle | 0.34343331 |
| 161 | MP0005666_abnormal_adipose_tissue | 0.33785748 |
| 162 | MP0009115_abnormal_fat_cell | 0.33328034 |
| 163 | MP0000427_abnormal_hair_cycle | 0.33029955 |
| 164 | MP0003453_abnormal_keratinocyte_physiol | 0.31727032 |
| 165 | MP0008872_abnormal_physiological_respon | 0.31344302 |
| 166 | MP0002419_abnormal_innate_immunity | 0.30448925 |
| 167 | MP0000249_abnormal_blood_vessel | 0.30429677 |
| 168 | MP0005248_abnormal_Harderian_gland | 0.29709314 |
| 169 | MP0005025_abnormal_response_to | 0.29608674 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.29185730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.50157374 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.18886668 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.18277453 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.58247089 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.55097179 |
| 6 | Complement deficiency (HP:0004431) | 6.24676978 |
| 7 | Xanthomatosis (HP:0000991) | 6.24395957 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 6.12185861 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.20354385 |
| 10 | Joint hemorrhage (HP:0005261) | 4.79356758 |
| 11 | Epidermoid cyst (HP:0200040) | 4.68500669 |
| 12 | Abnormality of complement system (HP:0005339) | 4.59702532 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.55839648 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45189088 |
| 15 | Hyperammonemia (HP:0001987) | 4.38360839 |
| 16 | Hyperglycinemia (HP:0002154) | 4.32647603 |
| 17 | Fat malabsorption (HP:0002630) | 4.30227925 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23099226 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16650934 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14793765 |
| 21 | Ketosis (HP:0001946) | 4.10650178 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.05274224 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98361948 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.97124437 |
| 25 | Pancreatic cysts (HP:0001737) | 3.81026332 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.75501053 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75483479 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.75483479 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.73446227 |
| 30 | Hyperglycinuria (HP:0003108) | 3.73024061 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71020343 |
| 32 | Thyroiditis (HP:0100646) | 3.61935633 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.53650369 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.50461833 |
| 35 | Methylmalonic acidemia (HP:0002912) | 3.46145934 |
| 36 | Pendular nystagmus (HP:0012043) | 3.44063780 |
| 37 | Pancreatic fibrosis (HP:0100732) | 3.35049599 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.34301575 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.31033558 |
| 40 | Steatorrhea (HP:0002570) | 3.30348480 |
| 41 | Abolished electroretinogram (ERG) (HP:0000550) | 3.30009291 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27089096 |
| 43 | Myocardial infarction (HP:0001658) | 3.22856303 |
| 44 | True hermaphroditism (HP:0010459) | 3.19927625 |
| 45 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.17768295 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.15336104 |
| 47 | Hyperbilirubinemia (HP:0002904) | 3.15195100 |
| 48 | IgG deficiency (HP:0004315) | 3.06593045 |
| 49 | Spontaneous abortion (HP:0005268) | 3.02698702 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01574142 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.95262330 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.93643418 |
| 53 | Skin nodule (HP:0200036) | 2.91582498 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.89844036 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.85334600 |
| 56 | Abnormality of the renal cortex (HP:0011035) | 2.82323541 |
| 57 | Asplenia (HP:0001746) | 2.78539953 |
| 58 | Ketoacidosis (HP:0001993) | 2.77143948 |
| 59 | Genetic anticipation (HP:0003743) | 2.74176685 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.70337062 |
| 61 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66733127 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.65638100 |
| 63 | Molar tooth sign on MRI (HP:0002419) | 2.65015813 |
| 64 | Abnormality of midbrain morphology (HP:0002418) | 2.65015813 |
| 65 | Nephronophthisis (HP:0000090) | 2.64118666 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.63596116 |
| 67 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.61971833 |
| 68 | Conjunctival hamartoma (HP:0100780) | 2.61515913 |
| 69 | Decreased central vision (HP:0007663) | 2.57899133 |
| 70 | Acanthocytosis (HP:0001927) | 2.56697303 |
| 71 | Metabolic acidosis (HP:0001942) | 2.55562394 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.55205780 |
| 73 | Increased corneal curvature (HP:0100692) | 2.53182110 |
| 74 | Keratoconus (HP:0000563) | 2.53182110 |
| 75 | Mitral stenosis (HP:0001718) | 2.52056084 |
| 76 | Vascular calcification (HP:0004934) | 2.50740687 |
| 77 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.48211630 |
| 78 | Gout (HP:0001997) | 2.47927885 |
| 79 | Neonatal onset (HP:0003623) | 2.47002126 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.44610670 |
| 81 | Spastic diplegia (HP:0001264) | 2.42503285 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.41880666 |
| 83 | Cholecystitis (HP:0001082) | 2.41880666 |
| 84 | Hamartoma of the eye (HP:0010568) | 2.41801739 |
| 85 | Lethargy (HP:0001254) | 2.39515515 |
| 86 | Cholelithiasis (HP:0001081) | 2.38922214 |
| 87 | Glomerulonephritis (HP:0000099) | 2.36192501 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.33711356 |
| 89 | Amyloidosis (HP:0011034) | 2.33369814 |
| 90 | Abnormality of T cell number (HP:0011839) | 2.33307091 |
| 91 | Irritability (HP:0000737) | 2.32066686 |
| 92 | Gingival bleeding (HP:0000225) | 2.30933253 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28996517 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.28996517 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.28895087 |
| 96 | Furrowed tongue (HP:0000221) | 2.28547802 |
| 97 | Absent thumb (HP:0009777) | 2.27792460 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 2.27359322 |
| 99 | Abnormality of DNA repair (HP:0003254) | 2.25592150 |
| 100 | Stomatitis (HP:0010280) | 2.24513109 |
| 101 | Gaze-evoked nystagmus (HP:0000640) | 2.22608509 |
| 102 | Progressive cerebellar ataxia (HP:0002073) | 2.22492559 |
| 103 | Cardiovascular calcification (HP:0011915) | 2.21904193 |
| 104 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21296108 |
| 105 | Cerebral edema (HP:0002181) | 2.21022682 |
| 106 | Abnormality of eosinophils (HP:0001879) | 2.20430232 |
| 107 | Congenital sensorineural hearing impairment (HP:0008527) | 2.19735769 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.18407753 |
| 109 | T lymphocytopenia (HP:0005403) | 2.16720630 |
| 110 | Pancreatitis (HP:0001733) | 2.16619569 |
| 111 | Esophageal varix (HP:0002040) | 2.16612740 |
| 112 | Malnutrition (HP:0004395) | 2.14454581 |
| 113 | Agitation (HP:0000713) | 2.13073862 |
| 114 | Thrombophlebitis (HP:0004418) | 2.12767900 |
| 115 | Menorrhagia (HP:0000132) | 2.11928597 |
| 116 | Chronic hepatic failure (HP:0100626) | 2.10333636 |
| 117 | Azoospermia (HP:0000027) | 2.09935286 |
| 118 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.08679224 |
| 119 | Prostate neoplasm (HP:0100787) | 2.08504223 |
| 120 | Brushfield spots (HP:0001088) | 2.07294273 |
| 121 | Abnormality of B cell number (HP:0010975) | 2.06212923 |
| 122 | Neoplasm of the adrenal cortex (HP:0100641) | 2.06176009 |
| 123 | Abnormality of homocysteine metabolism (HP:0010919) | 2.03453515 |
| 124 | Homocystinuria (HP:0002156) | 2.03453515 |
| 125 | Hypoproteinemia (HP:0003075) | 2.03409864 |
| 126 | Enlarged kidneys (HP:0000105) | 2.03294095 |
| 127 | Abnormality of the gallbladder (HP:0005264) | 2.02802935 |
| 128 | Cystic liver disease (HP:0006706) | 2.02593599 |
| 129 | Severe visual impairment (HP:0001141) | 2.01180301 |
| 130 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.00561108 |
| 131 | Short 1st metacarpal (HP:0010034) | 2.00561108 |
| 132 | Congenital, generalized hypertrichosis (HP:0004540) | 2.00328906 |
| 133 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.96336888 |
| 134 | Late onset (HP:0003584) | 1.96162832 |
| 135 | Porencephaly (HP:0002132) | 1.96092793 |
| 136 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.95545667 |
| 137 | Attenuation of retinal blood vessels (HP:0007843) | 1.95534651 |
| 138 | Bile duct proliferation (HP:0001408) | 1.95056893 |
| 139 | Abnormal biliary tract physiology (HP:0012439) | 1.95056893 |
| 140 | Abnormal spermatogenesis (HP:0008669) | 1.95054601 |
| 141 | Abnormality of the labia minora (HP:0012880) | 1.94940716 |
| 142 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.94361075 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93833543 |
| 144 | Rickets (HP:0002748) | 1.93655113 |
| 145 | Combined immunodeficiency (HP:0005387) | 1.93362784 |
| 146 | Opisthotonus (HP:0002179) | 1.92662873 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.92338923 |
| 148 | Vomiting (HP:0002013) | 1.92226786 |
| 149 | Abnormality of the renal collecting system (HP:0004742) | 1.91853543 |
| 150 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.91343381 |
| 151 | Abnormality of proline metabolism (HP:0010907) | 1.91157288 |
| 152 | Hydroxyprolinuria (HP:0003080) | 1.91157288 |
| 153 | Abnormality of chromosome stability (HP:0003220) | 1.90774961 |
| 154 | Sclerocornea (HP:0000647) | 1.88978107 |
| 155 | Mesomelia (HP:0003027) | 1.88936404 |
| 156 | Abnormality of the prostate (HP:0008775) | 1.88910608 |
| 157 | Carpal bone hypoplasia (HP:0001498) | 1.88719553 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88255987 |
| 159 | Male pseudohermaphroditism (HP:0000037) | 1.87435616 |
| 160 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.86989772 |
| 161 | Poikilocytosis (HP:0004447) | 1.86989576 |
| 162 | Meckel diverticulum (HP:0002245) | 1.86587327 |
| 163 | Abnormality of the axillary hair (HP:0100134) | 1.85901777 |
| 164 | Abnormality of secondary sexual hair (HP:0009888) | 1.85901777 |
| 165 | Status epilepticus (HP:0002133) | 1.85602648 |
| 166 | B lymphocytopenia (HP:0010976) | 1.85147426 |
| 167 | Abnormality of the ileum (HP:0001549) | 1.85051375 |
| 168 | Generalized aminoaciduria (HP:0002909) | 1.84791601 |
| 169 | Eosinophilia (HP:0001880) | 1.84437464 |
| 170 | Hypophosphatemic rickets (HP:0004912) | 1.84165745 |
| 171 | Progressive inability to walk (HP:0002505) | 1.84071968 |
| 172 | Abnormality of vitamin B metabolism (HP:0004340) | 1.83706311 |
| 173 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83234961 |
| 174 | Autoimmune hemolytic anemia (HP:0001890) | 1.82820039 |
| 175 | Goiter (HP:0000853) | 1.82795822 |
| 176 | Elevated hepatic transaminases (HP:0002910) | 1.82517773 |
| 177 | Abnormal cartilage morphology (HP:0002763) | 1.80877544 |
| 178 | Stomach cancer (HP:0012126) | 1.80332920 |
| 179 | Meningioma (HP:0002858) | 1.78603125 |
| 180 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78015445 |
| 181 | Hypothermia (HP:0002045) | 1.77494207 |
| 182 | Confusion (HP:0001289) | 1.77163502 |
| 183 | Elevated alkaline phosphatase (HP:0003155) | 1.76512470 |
| 184 | Nephritis (HP:0000123) | 1.75664066 |
| 185 | Abnormality of the nasal septum (HP:0000419) | 1.75142999 |
| 186 | Alkalosis (HP:0001948) | 1.75060633 |
| 187 | Renal cortical cysts (HP:0000803) | 1.73722694 |
| 188 | Pulmonary embolism (HP:0002204) | 1.73660941 |
| 189 | Chorioretinal atrophy (HP:0000533) | 1.73041616 |
| 190 | Abnormality of the 1st metacarpal (HP:0010009) | 1.71859185 |
| 191 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71159959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.90447119 |
| 2 | ERN1 | 4.56331508 |
| 3 | FGFR4 | 4.55825354 |
| 4 | SIK1 | 4.04356194 |
| 5 | ERBB4 | 3.93678449 |
| 6 | NUAK1 | 3.50138320 |
| 7 | TAOK3 | 3.39405314 |
| 8 | TXK | 3.18257718 |
| 9 | ADRBK2 | 2.63441712 |
| 10 | INSRR | 2.59081136 |
| 11 | MAP4K2 | 2.52711570 |
| 12 | BMPR1B | 2.52148616 |
| 13 | ZAK | 2.47747782 |
| 14 | MAP2K4 | 2.32936402 |
| 15 | EIF2AK3 | 2.32000623 |
| 16 | ACVR1B | 2.21903471 |
| 17 | MAPK11 | 2.17061993 |
| 18 | TYK2 | 2.13186800 |
| 19 | TLK1 | 2.09094640 |
| 20 | MST1R | 2.02931447 |
| 21 | MST4 | 1.94506519 |
| 22 | MAP3K14 | 1.81539368 |
| 23 | VRK2 | 1.70342843 |
| 24 | VRK1 | 1.69758243 |
| 25 | TBK1 | 1.68380106 |
| 26 | NEK1 | 1.67277723 |
| 27 | WNK3 | 1.63788198 |
| 28 | NEK9 | 1.63215854 |
| 29 | ABL2 | 1.59865249 |
| 30 | LATS1 | 1.56644171 |
| 31 | JAK1 | 1.56054351 |
| 32 | DAPK2 | 1.53634717 |
| 33 | PKN2 | 1.50916039 |
| 34 | JAK2 | 1.48783353 |
| 35 | TNIK | 1.48782439 |
| 36 | PIK3CG | 1.43828066 |
| 37 | TRIM28 | 1.42823490 |
| 38 | FLT3 | 1.40614695 |
| 39 | TAF1 | 1.39820607 |
| 40 | PTK6 | 1.39357169 |
| 41 | TRIB3 | 1.38877926 |
| 42 | NLK | 1.34932365 |
| 43 | PLK3 | 1.31255047 |
| 44 | BUB1 | 1.25557487 |
| 45 | ERBB2 | 1.22144346 |
| 46 | MKNK2 | 1.22105101 |
| 47 | FGFR2 | 1.21785732 |
| 48 | STK16 | 1.18721143 |
| 49 | TEC | 1.18363105 |
| 50 | EPHB1 | 1.18355585 |
| 51 | MAP3K7 | 1.17674207 |
| 52 | FRK | 1.14402266 |
| 53 | IKBKE | 1.14347926 |
| 54 | OXSR1 | 1.10271974 |
| 55 | PINK1 | 1.04937441 |
| 56 | PLK2 | 1.02464401 |
| 57 | MAP3K13 | 1.02141949 |
| 58 | MAPK13 | 1.01311321 |
| 59 | PRKAA2 | 0.98994755 |
| 60 | GRK7 | 0.98890939 |
| 61 | KDR | 0.96390209 |
| 62 | CAMKK2 | 0.95285116 |
| 63 | ITK | 0.93652829 |
| 64 | IRAK3 | 0.93641088 |
| 65 | GRK6 | 0.92359698 |
| 66 | EPHA3 | 0.90239928 |
| 67 | STK39 | 0.90152934 |
| 68 | PRKCZ | 0.89881320 |
| 69 | EIF2AK1 | 0.88918624 |
| 70 | EIF2AK2 | 0.88911472 |
| 71 | MAPK4 | 0.87102364 |
| 72 | PIK3CA | 0.86474006 |
| 73 | PKN1 | 0.85014328 |
| 74 | CSK | 0.79353333 |
| 75 | PBK | 0.79208396 |
| 76 | BRSK2 | 0.78940959 |
| 77 | WNK4 | 0.78891924 |
| 78 | GRK5 | 0.78381931 |
| 79 | CDK6 | 0.77261860 |
| 80 | FGFR3 | 0.76878673 |
| 81 | CAMK2G | 0.76171752 |
| 82 | ERBB3 | 0.75275929 |
| 83 | MAP2K3 | 0.74715534 |
| 84 | MAP3K10 | 0.74169257 |
| 85 | MET | 0.72382472 |
| 86 | PRKACG | 0.70180873 |
| 87 | DYRK2 | 0.68802964 |
| 88 | CASK | 0.68618053 |
| 89 | TSSK6 | 0.66967178 |
| 90 | CSNK1G3 | 0.66806168 |
| 91 | SGK3 | 0.66481109 |
| 92 | DYRK1B | 0.65521727 |
| 93 | PRKCQ | 0.64474784 |
| 94 | CSNK1G2 | 0.64222941 |
| 95 | PRKD2 | 0.63984635 |
| 96 | GSK3A | 0.63604810 |
| 97 | MAP3K11 | 0.61935682 |
| 98 | SYK | 0.61512941 |
| 99 | ADRBK1 | 0.61505428 |
| 100 | LCK | 0.61307576 |
| 101 | MAPK12 | 0.60990812 |
| 102 | RIPK1 | 0.60213389 |
| 103 | MAP3K3 | 0.60111619 |
| 104 | PRKCE | 0.60073611 |
| 105 | PIM1 | 0.59891227 |
| 106 | MARK3 | 0.59873721 |
| 107 | PRKCI | 0.59715130 |
| 108 | IRAK2 | 0.59405441 |
| 109 | STK38L | 0.59132890 |
| 110 | PDPK1 | 0.58982242 |
| 111 | PRKAA1 | 0.58946761 |
| 112 | RET | 0.58229967 |
| 113 | MUSK | 0.57744879 |
| 114 | IRAK1 | 0.57340928 |
| 115 | MAPK15 | 0.56413514 |
| 116 | TGFBR1 | 0.54804079 |
| 117 | MAP3K5 | 0.54433227 |
| 118 | MAPKAPK5 | 0.54313821 |
| 119 | MAP3K1 | 0.53701981 |
| 120 | CSF1R | 0.53473937 |
| 121 | JAK3 | 0.53220929 |
| 122 | PTK2 | 0.52706436 |
| 123 | MAPKAPK3 | 0.52353026 |
| 124 | PLK4 | 0.51697282 |
| 125 | CSNK1A1L | 0.51606319 |
| 126 | LYN | 0.51545900 |
| 127 | MAP2K6 | 0.50529875 |
| 128 | BMX | 0.50319779 |
| 129 | RPS6KA5 | 0.50207815 |
| 130 | AKT3 | 0.49455595 |
| 131 | CAMK1D | 0.49232746 |
| 132 | PASK | 0.48065940 |
| 133 | KSR2 | 0.47871830 |
| 134 | ICK | 0.47592992 |
| 135 | CDC7 | 0.47294154 |
| 136 | EGFR | 0.46548191 |
| 137 | SGK2 | 0.46486765 |
| 138 | EPHA4 | 0.46296486 |
| 139 | BCR | 0.45798524 |
| 140 | IGF1R | 0.43526042 |
| 141 | FES | 0.43363349 |
| 142 | IKBKB | 0.42454425 |
| 143 | MKNK1 | 0.41661995 |
| 144 | BTK | 0.40612871 |
| 145 | PTK2B | 0.40276198 |
| 146 | PDK1 | 0.39581030 |
| 147 | MAPK7 | 0.39100638 |
| 148 | CSNK1A1 | 0.38293114 |
| 149 | MAP3K12 | 0.37504882 |
| 150 | HCK | 0.36407165 |
| 151 | ABL1 | 0.36361707 |
| 152 | NME1 | 0.35892068 |
| 153 | SGK494 | 0.35735180 |
| 154 | SGK223 | 0.35735180 |
| 155 | MAP2K1 | 0.35687789 |
| 156 | MELK | 0.35266566 |
| 157 | MAP4K1 | 0.34991580 |
| 158 | CHUK | 0.34581889 |
| 159 | PRKCG | 0.34146875 |
| 160 | ZAP70 | 0.33680230 |
| 161 | PRKACA | 0.33392631 |
| 162 | ATR | 0.33141987 |
| 163 | LATS2 | 0.32518721 |
| 164 | MAP3K4 | 0.32375517 |
| 165 | PRKCH | 0.31973642 |
| 166 | PLK1 | 0.31376249 |
| 167 | CSNK1G1 | 0.31091354 |
| 168 | MAP3K6 | 0.30726976 |
| 169 | MAP3K2 | 0.30461822 |
| 170 | KIT | 0.29442005 |
| 171 | TAOK2 | 0.28766768 |
| 172 | GRK1 | 0.28082286 |
| 173 | CDK4 | 0.26801925 |
| 174 | PRKCA | 0.26636936 |
| 175 | PAK3 | 0.26444254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.92115194 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60324873 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.52503442 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18702343 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.14493716 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93456468 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74542518 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58119889 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52662507 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51784717 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44903209 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.43211137 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29671843 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16961455 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.15516437 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09316862 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.07682129 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 2.00257641 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99456841 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.95496644 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90719494 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90133117 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88919177 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88515443 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81919569 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80911200 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80717228 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77234934 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.76498366 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73156529 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71038484 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67660440 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.66577107 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65667381 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63842680 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57607038 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57378696 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.56658026 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.55371553 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54710025 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.50497445 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47158563 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45967497 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45413350 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45378823 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43077950 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.42710343 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34458415 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.33705310 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32341483 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31305358 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30971247 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29983563 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28719875 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28522688 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28271957 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27707496 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26982580 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.23502678 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23495680 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21555090 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15956354 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14021239 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12078079 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11953985 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10556960 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10278149 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09064944 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08650264 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 1.08168705 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06153874 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04924678 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01291456 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98548786 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.90817539 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88944886 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87999342 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87762063 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86309794 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85749461 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85713195 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84988545 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.84898207 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81850688 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77470642 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.75065874 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70918406 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69865224 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68063365 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67380725 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.66137473 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66100455 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60977205 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.60616410 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59811378 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59611900 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59086748 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55724527 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53398729 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50189582 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48487009 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47302692 |
| 103 | Mismatch repair_Homo sapiens_hsa03430 | 0.46723188 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44782092 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42934876 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40812139 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.40288708 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.35275350 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33824977 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33797309 |
| 111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33018596 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32535225 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31780911 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30184907 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30082884 |
| 116 | Melanoma_Homo sapiens_hsa05218 | 0.29785062 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.26420473 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.26287046 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24955232 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20893976 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20584873 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20378556 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16802339 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15453060 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12237487 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11272864 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00143221 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | -0.2101151 |
| 129 | Malaria_Homo sapiens_hsa05144 | -0.2060871 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2057026 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2030538 |
| 132 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.1976007 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1786459 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1520930 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1516278 |
| 136 | Pertussis_Homo sapiens_hsa05133 | -0.1382965 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1306459 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1305914 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1225441 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | -0.1155184 |
| 141 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1073955 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0999927 |
| 143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0959810 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0916803 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0910705 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | -0.0896964 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0615762 |
| 148 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0268408 |

